Keywords: galapagos, considering, stock, exchange, listing, netherlands-based, genomics

Galapagos considering stock exchange listing

Article | 14 March 2005

Netherlands-based Galapagos Genomics NV, a genomics-based drug discovery company, has said that it is considering a Euronext stock exchange listing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Drug Discovery

GlaxoSmithKline

GSK

Go to company listing